BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Almaaitah S, Highland KB, Tonelli AR. Management of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis. Integr Blood Press Control 2020;13:15-29. [PMID: 32280271 DOI: 10.2147/IBPC.S232038] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Misra DP, Ahmed S, Goyal M, Sharma A, Agarwal V. Venous Thromboembolism in the Inflammatory Rheumatic Diseases. Rheumatic Disease Clinics of North America 2023;49:97-127. [DOI: 10.1016/j.rdc.2022.08.001] [Reference Citation Analysis]
2 Murdaca G, Noberasco G, Olobardi D, Ogliastro M, Sibilio R, Sambuceti G, Balzano R, Sticchi L, Icardi G, Orsi A. Systemic sclerosis and vaccinations: a three-year register-based cohort study about vaccination rate and uptake from Liguria referral center, northwest Italy. Hum Vaccin Immunother 2022;18:2025732. [PMID: 35258440 DOI: 10.1080/21645515.2022.2025732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chennakesavulu PV, Uppaluri S, Koyi J, Jhaveri S, Avanthika C, Sakhamuri LT, Ashokbhai PK, Singh P. Pulmonary Hypertension in Scleroderma- Evaluation and Management. Dis Mon 2022;:101468. [PMID: 36163292 DOI: 10.1016/j.disamonth.2022.101468] [Reference Citation Analysis]
4 Skov M, Anees S. Atypical presentation and progression of scleroderma associated interstitial lung disease. Pneumon 2022;35:1-6. [DOI: 10.18332/pne/149901] [Reference Citation Analysis]
5 Tamura Y, Kumamaru H, Inami T, Matsubara H, Hirata K, Tsujino I, Suda R, Miyata H, Nishimura S, Sigel B, Takano M, Tatsumi K. Changes in the Characteristics and Initial Treatments of Pulmonary Hypertension Between 2008 and 2020 in Japan. JACC: Asia 2022;2:273-284. [DOI: 10.1016/j.jacasi.2022.02.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Matsui T, Kikuchi N, Serizawa N, Hagiwara N. Systemic sclerosis complicated by chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty: a case report. European Heart Journal - Case Reports 2022;6. [DOI: 10.1093/ehjcr/ytac080] [Reference Citation Analysis]
7 Al Abdi S, Almoushref A, Naal T, Melillo CA, Aulak KS, Ahmed MK, Chatterjee S, Highland KB, Dweik RA, Tonelli AR. Cutaneous iontophoresis of vasoactive medications in patients with scleroderma-associated pulmonary arterial hypertension. Microcirculation 2021;:e12734. [PMID: 34741773 DOI: 10.1111/micc.12734] [Reference Citation Analysis]
8 Zhang Y, Qin D, Qin L, Yang X, Luo Q, Wang H. Diagnostic value of cardiac natriuretic peptide on pulmonary hypertension in systemic sclerosis: A systematic review and meta-analysis. Joint Bone Spine 2021;89:105287. [PMID: 34601113 DOI: 10.1016/j.jbspin.2021.105287] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Giucă A, Mihai C, Jurcuț C, Gheorghiu AM, Groșeanu L, Dima A, Săftoiu A, Coman IM, Popescu BA, Jurcuț R. Screening for Pulmonary Hypertension in Systemic Sclerosis-A Primer for Cardio-Rheumatology Clinics. Diagnostics (Basel) 2021;11:1013. [PMID: 34206055 DOI: 10.3390/diagnostics11061013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Su L, Zhang N, Wang H, Yang Z, Wei W. Relapsing polychondritis presenting 2 years after systemic sclerosis with pulmonary arterial hypertension. Rheumatology and Immunology Research 2021;2:121-3. [DOI: 10.2478/rir-2021-0016] [Reference Citation Analysis]
11 Naranjo M, Hassoun PM. Systemic Sclerosis-Associated Pulmonary Hypertension: Spectrum and Impact. Diagnostics (Basel) 2021;11:911. [PMID: 34065226 DOI: 10.3390/diagnostics11050911] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
12 Castañeda NG, Rubio ER, Emperiale V, Hajkhan AM. Esclerosis sistémica. Medicine - Programa de Formación Médica Continuada Acreditado 2021;13:1769-1778. [DOI: 10.1016/j.med.2021.04.004] [Reference Citation Analysis]
13 Attanasio U, Cuomo A, Pirozzi F, Loffredo S, Abete P, Petretta M, Marone G, Bonaduce D, De Paulis A, Rossi FW, Tocchetti CG, Mercurio V. Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment. Int J Mol Sci 2020;21:E4430. [PMID: 32580360 DOI: 10.3390/ijms21124430] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
14 Murdaca G, Noberasco G, Battaglini A, Vassallo C, Giusti F, Greco M, Schiavi C, Sticchi L, Icardi G, Orsi A. Systemic Sclerosis and Vaccinations: A Register-Based Cohort Study about Seasonal Influenza and Streptococcus pneumoniae Vaccination Rate and Uptake from Liguria Regional Center, Northwest Italy. Vaccines (Basel) 2020;8:E204. [PMID: 32354027 DOI: 10.3390/vaccines8020204] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]